Intrinsic Value of S&P & Nasdaq Contact Us

Frequency Therapeutics, Inc. FREQ NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
42/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.40
+367.3%

Frequency Therapeutics, Inc. (FREQ) — Analyst outlook / Analyst consensus target is. Based on 7 analyst ratings, the consensus is bullish — 3 Buy, 4 Hold.

The consensus price target is $1.40, representing an upside of 367.3% from the current price $0.30.

FREQ Stock — 12-Month Price Forecast

$1.40
▲ +367.29% Upside
Average Price Target
Based on 7 Wall Street analysts offering 12-month price targets for Frequency Therapeutics, Inc., the price target is $1.40.
The average price target represents a +367.29% change from the last price of $0.30.

FREQ Analyst Ratings

Hold
7
Ratings
3 Buy
4 Hold
Based on 7 analysts giving stock ratings to Frequency Therapeutics, Inc. in the past 3 months
Rating breakdown
Buy
3 43%
Hold
4 57%
43%
Buy
3 analysts
57%
Hold
4 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message